Description
Brand: Biovisc
Manufacturer: Biotech Healthcare
Country of origin: Switzerland
CE-mark: This product has a CE-mark
Biovisc Ortho M is a 2 mL syringe containing 2% Hyaluronic Acid (40 mg) combined with 0.5% Mannitol (10 mg). This advanced formulation provides enhanced joint lubrication and protection, with Mannitol acting as an antioxidant to stabilize the hyaluronic acid and prolong its effectiveness. Designed for optimal joint health, it offers superior viscoelastic properties and long-lasting relief for improved mobility and comfort.